Literature DB >> 32531063

Health and Economic Impact of Health Warnings and Plain Tobacco Packaging in Seven Latin American Countries: Results of a Simulation Model.

Andrea Alcaraz1, Akram Hernández-Vásquez1, Alfredo Palacios1, Belén Rodríguez1, Javier Roberti1, Sebastián García-Martí1, Agustín Ciapponi1, Federico Augustovski1, Ariel Bardach1, Andrés Pichon-Riviere1.   

Abstract

INTRODUCTION: The burden of disease attributable to tobacco use in Latin America is very high. Our objective was to evaluate the 10-year potential impact of current legislation related to cigarette packaging and warnings and expected effects of moving to a higher level of strategies implementing cigarette plain packaging on health and cost outcomes in Argentina, Bolivia, Brazil, Chile, Colombia, Mexico, and Peru, using a microsimulation model. AIMS AND METHODS: We used a probabilistic state-transition microsimulation model, considering natural history, costs, and quality of life losses associated with main tobacco-related diseases. We followed up individuals in hypothetical cohorts and calculated health outcomes annually to obtain aggregated long-term population health outcomes and costs. We performed a literature review to estimate effects and analyzed studies and information from ministries, relevant organizations, and national surveys. We calibrated the model comparing the predicted disease-specific mortality rates with local statistics.
RESULTS: Current graphic warnings already in place in each country could avert, during 10 years, 69 369 deaths and 638 295 disease events, adding 1.2 million years of healthy life and saving USD 5.3 billion in the seven countries. If these countries implemented plain packaging strategies, additional 155 857 premature deaths and 4 133 858 events could be averted, adding 4.1 million healthy years of life and saving USD 13.6 billion in direct health care expenses of diseases attributable to smoking.
CONCLUSIONS: Latin American countries should not delay the implementation of this strategy that will alleviate part of the enormous health and financial burden that tobacco poses on their economies and health care systems. IMPLICATIONS: Tobacco smoking is the single most preventable and premature mortality cause in the world. The Framework Convention on Tobacco Control, supported by the World Health Organization, introduced a package of evidence-based measures for tobacco control. This study adds evidence on the potential health effects and savings of implementing cigarette plain packaging in countries representing almost 80% of the Latin American population; findings are valuable resources for policy makers in the region.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved.For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 32531063     DOI: 10.1093/ntr/ntaa104

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  3 in total

1.  Estimated Prevalence of Smoking and Smoking-Attributable Mortality Associated With Graphic Health Warnings on Cigarette Packages in the US From 2022 to 2100.

Authors:  Jamie Tam; Jihyoun Jeon; James F Thrasher; David Hammond; Theodore R Holford; David T Levy; Rafael Meza
Journal:  JAMA Health Forum       Date:  2021-09-24

2.  Standardised packs and larger health warnings: visual attention and perceptions among Colombian smokers and non-smokers.

Authors:  Carlos Sillero-Rejon; Osama Mahmoud; Ricardo M Tamayo; Alvaro Arturo Clavijo-Alvarez; Sally Adams; Olivia M Maynard
Journal:  Addiction       Date:  2022-01-08       Impact factor: 7.256

3.  Optimizing Tobacco Advertising Bans in Seven Latin American Countries: Microsimulation Modeling of Health and Financial Impact to Inform Evidence-Based Policy.

Authors:  Ariel Bardach; Andrea Alcaraz; Javier Roberti; Agustín Ciapponi; Federico Augustovski; Andrés Pichon-Riviere
Journal:  Int J Environ Res Public Health       Date:  2021-05-11       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.